Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2010

Open Access 01-12-2010 | Research

Preferences of diabetes patients and physicians: A feasibility study to identify the key indicators for appraisal of health care values

Authors: Franz Porzsolt, Johannes Clouth, Marc Deutschmann, Hans-J Hippler

Published in: Health and Quality of Life Outcomes | Issue 1/2010

Login to get access

Abstract

Background

Evidence-based medicine, the Institute of Medicine (IOM) and the German Institute for Quality and Efficiency in Health Care (IQWiG), support the inclusion of patients' preferences in health care decisions. In fact there are not many trials which include an assessment of patient's preferences. The aim of this study is to demonstrate that preferences of physicians and of patients can be assessed and that this information may be helpful for medical decision making.

Method

One of the established methods for assessment of preferences is the conjoint analysis. Conjoint analysis, in combination with a computer assisted telephone interview (CATI), was used to collect data from 827 diabetes patients and 60 physicians, which describe the preferences expressed as levels of four factors in the management and outcome of the disease. The first factor described the main treatment effect (reduction of elevated HbA1c, improved well-being, absence of side effects, and no limitations of daily life). The second factor described the effect on the body weight (gain, no change, reduction). The third factor analyzed the mode of application (linked to meals or flexible application). The fourth factor addressed the type of product (original brand or generic product). Utility values were scaled and normalized in a way that the sum of utility points across all levels is equal to the number of attributes (factors) times 100.

Results

The preference weights confirm that the reduction of body weight is at least as important for patients - especially obese patients - and physicians as the reduction of an elevated HbA1c. Original products were preferred by patients while general practitioners preferred generic products.

Conclusion

Using the example of diabetes, the difference between patients' and physicians' preferences can be assessed. The use of a conjoint analysis in combination with CATI seems to be an effective approach for generation of data which are needed for policy and medical decision making in health care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gray JA Muir: Evidence-based policy making - is about taking decisions based on evidence and the needs and values of the population. BMJ 2004, 329: 988–989. 10.1136/bmj.329.7473.988CrossRef Gray JA Muir: Evidence-based policy making - is about taking decisions based on evidence and the needs and values of the population. BMJ 2004, 329: 988–989. 10.1136/bmj.329.7473.988CrossRef
2.
go back to reference Laurence C, Gialamas A, Yelland L, Bubner T, Ryan P, Willson K, Glastonbury B, Gill J, Shephard M, Beilby J, for members of the PoCT Trial Management Committee: A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics. Trials 2008, 9: 50. 10.1186/1745-6215-9-50PubMedCentralPubMedCrossRef Laurence C, Gialamas A, Yelland L, Bubner T, Ryan P, Willson K, Glastonbury B, Gill J, Shephard M, Beilby J, for members of the PoCT Trial Management Committee: A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics. Trials 2008, 9: 50. 10.1186/1745-6215-9-50PubMedCentralPubMedCrossRef
3.
go back to reference Friedman LM, Furberg CD, DeMets DL: Fundamentals of Clinical Trials. 2nd edition. Boston: PSG, Inc; 1985. Friedman LM, Furberg CD, DeMets DL: Fundamentals of Clinical Trials. 2nd edition. Boston: PSG, Inc; 1985.
4.
go back to reference Godwin M, Ruhland L, Casson I, MacDonald S, Delva D, Birtwhistle R, Lam M, Seguin R: Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med Res Methodol 2003, 3: 28. 10.1186/1471-2288-3-28PubMedCentralPubMedCrossRef Godwin M, Ruhland L, Casson I, MacDonald S, Delva D, Birtwhistle R, Lam M, Seguin R: Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med Res Methodol 2003, 3: 28. 10.1186/1471-2288-3-28PubMedCentralPubMedCrossRef
5.
go back to reference Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K: A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009, 62: 464–475. 10.1016/j.jclinepi.2008.12.011PubMedCrossRef Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K: A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009, 62: 464–475. 10.1016/j.jclinepi.2008.12.011PubMedCrossRef
6.
go back to reference Straus SE, Richardson WS, Glasziou P, Haynes RB: Evidence-Based Medicine. How to practice and teach EBM. Edinburgh: Elsevier Churchill Livingstone; 2005. Straus SE, Richardson WS, Glasziou P, Haynes RB: Evidence-Based Medicine. How to practice and teach EBM. Edinburgh: Elsevier Churchill Livingstone; 2005.
7.
go back to reference Porzsolt F, Pressel H, Maute-Stephan C, KIndervater R, Geldmacher J, Meierkord S, Sigle JM, Eisemann M: Appraisal of healthcare: from patient value to societal benefit. J Publ Health 2009. Porzsolt F, Pressel H, Maute-Stephan C, KIndervater R, Geldmacher J, Meierkord S, Sigle JM, Eisemann M: Appraisal of healthcare: from patient value to societal benefit. J Publ Health 2009.
8.
go back to reference Pindyck RS, Rubinfeld DL: Microeconomics. 6th edition. New Jersey: Prentice Hall; 2005. Pindyck RS, Rubinfeld DL: Microeconomics. 6th edition. New Jersey: Prentice Hall; 2005.
9.
go back to reference Beresniak A, Russell AS, Haraoui B, Bessette L, Bombardier C, Duru G: Advantages and limitations of utility assessment methods in rheumatoid arthritis. J Rheumatol 2007, 34: 2193–2200.PubMed Beresniak A, Russell AS, Haraoui B, Bessette L, Bombardier C, Duru G: Advantages and limitations of utility assessment methods in rheumatoid arthritis. J Rheumatol 2007, 34: 2193–2200.PubMed
10.
go back to reference Kymes SM, Lee BS: Preference-based quality of life measures in people with visual impairment. Optom Vis Sci 2007, 84: 809–816. 10.1097/OPX.0b013e3181337638PubMedCrossRef Kymes SM, Lee BS: Preference-based quality of life measures in people with visual impairment. Optom Vis Sci 2007, 84: 809–816. 10.1097/OPX.0b013e3181337638PubMedCrossRef
11.
go back to reference Huang ES, Shook M, Jin L, Chin MH, Meltzer DO: The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care 2006, 29: 259–64. 10.2337/diacare.29.02.06.dc05-1443PubMedCentralPubMedCrossRef Huang ES, Shook M, Jin L, Chin MH, Meltzer DO: The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care 2006, 29: 259–64. 10.2337/diacare.29.02.06.dc05-1443PubMedCentralPubMedCrossRef
12.
go back to reference Kornmann M, Porzsolt F: Treatment preferences of physicians and lay persons: lessons from a study analysing neoadjuvant treatment of rectal carcinoma. J Clin Oncol 2008, 26: 2866–4868. 10.1200/JCO.2008.16.2891CrossRef Kornmann M, Porzsolt F: Treatment preferences of physicians and lay persons: lessons from a study analysing neoadjuvant treatment of rectal carcinoma. J Clin Oncol 2008, 26: 2866–4868. 10.1200/JCO.2008.16.2891CrossRef
13.
go back to reference Phillips KA, Maddala T, Johnson FR: Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res 2002, 37: 1681–1705. 10.1111/1475-6773.01115PubMedCentralPubMedCrossRef Phillips KA, Maddala T, Johnson FR: Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res 2002, 37: 1681–1705. 10.1111/1475-6773.01115PubMedCentralPubMedCrossRef
14.
go back to reference Ratcliffe J, Van Haselen R, Buxton M, Hardy K, Colehan J, Partridge M: Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study. Thorax 2002, 57: 503–508. 10.1136/thorax.57.6.503PubMedCentralPubMedCrossRef Ratcliffe J, Van Haselen R, Buxton M, Hardy K, Colehan J, Partridge M: Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study. Thorax 2002, 57: 503–508. 10.1136/thorax.57.6.503PubMedCentralPubMedCrossRef
15.
go back to reference Ross M, Avery A, Foss A: Views of older people on cataract surgery options: an assessment of preferences by conjoint analysis. Qual Saf Health Care 2003, 12: 13–17. 10.1136/qhc.12.1.13PubMedCentralPubMedCrossRef Ross M, Avery A, Foss A: Views of older people on cataract surgery options: an assessment of preferences by conjoint analysis. Qual Saf Health Care 2003, 12: 13–17. 10.1136/qhc.12.1.13PubMedCentralPubMedCrossRef
17.
go back to reference Stiggelbout AM, de Vogel-Voogt E, Noordijk EM, Vliet Vlieland TP: Individual quality of life: adaptive conjoint analysis as an alternative for direct weighting? Qual Life Res 2008, 17: 641–649. 10.1007/s11136-008-9325-6PubMedCentralPubMedCrossRef Stiggelbout AM, de Vogel-Voogt E, Noordijk EM, Vliet Vlieland TP: Individual quality of life: adaptive conjoint analysis as an alternative for direct weighting? Qual Life Res 2008, 17: 641–649. 10.1007/s11136-008-9325-6PubMedCentralPubMedCrossRef
18.
go back to reference Kahneman D, Tversky A: An analysis of decision under risk. Prospect theory Econometrica 1979, 47: 263–291. Kahneman D, Tversky A: An analysis of decision under risk. Prospect theory Econometrica 1979, 47: 263–291.
19.
go back to reference Ortendahl M: Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis. Ther Clin Risk Manag 2007, 3: 1175–1180.PubMedCentralPubMed Ortendahl M: Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis. Ther Clin Risk Manag 2007, 3: 1175–1180.PubMedCentralPubMed
20.
go back to reference Chin MH, Drum ML, Jin L, Shook ME, Huang ES, Meltzer DO: Variation in treatment preferences and care goals among older patients with diabetes and their physicians. Med Care 2008, 46: 275–286. 10.1097/MLR.0b013e318158af40PubMedCentralPubMedCrossRef Chin MH, Drum ML, Jin L, Shook ME, Huang ES, Meltzer DO: Variation in treatment preferences and care goals among older patients with diabetes and their physicians. Med Care 2008, 46: 275–286. 10.1097/MLR.0b013e318158af40PubMedCentralPubMedCrossRef
21.
go back to reference Montori VM, Gafni A, Charles C: A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect 2006, 9: 25–36. 10.1111/j.1369-7625.2006.00359.xPubMedCrossRef Montori VM, Gafni A, Charles C: A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect 2006, 9: 25–36. 10.1111/j.1369-7625.2006.00359.xPubMedCrossRef
23.
go back to reference Committee on Comparative Effectiveness Research Prioritization, Institute of Medicine: Initial National Priorities for Comparative Effectiveness Research. Washington, DC: Institute of Medicine; 2009. Committee on Comparative Effectiveness Research Prioritization, Institute of Medicine: Initial National Priorities for Comparative Effectiveness Research. Washington, DC: Institute of Medicine; 2009.
Metadata
Title
Preferences of diabetes patients and physicians: A feasibility study to identify the key indicators for appraisal of health care values
Authors
Franz Porzsolt
Johannes Clouth
Marc Deutschmann
Hans-J Hippler
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2010
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-8-125

Other articles of this Issue 1/2010

Health and Quality of Life Outcomes 1/2010 Go to the issue